Where it's most often discussed: Tissue repair and recovery models (especially tendons/ligaments and muscle) Wound healing and regenerative signaling Gut integrity and inflammation-related pathways Where it's not firmly established: Extensive, rigorous human studies designed to measure fat loss outcomes (fat mass, waist circumference, body fat percentage) That distinction matters
The simple version: It's a chain of 15 amino acids that tells your body to heal damaged tissue faster
In people with obesity, 36 weeks of orforglipron (doses ranging from 12 to 45 mg in a phase 2 trial) resulted in a dose-dependent WL up to 14.7% compared to 2.3% with placebo, with concomitant improvement in cardiometabolic risk factors (Table 2) [25]
Also discard if the solution appears cloudy, contains particles, has been left at room temperature for more than 48 hours, or is past the 28-day mark
Compounding regulation is fact-specific and evolving